ACT-05 Present and future of precision-based medicine using cancer genome panels

Background: Two cancer genome panels were approved for use in Japan in 2019, and their application in brain tumors are awaited. We have used CANCERPLEXR and FoundationOne CDx (F1) panels for the realization of precision-based medicine in brain tumors. Patients and methods: From August 2017 to presen...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neurooncol Adv
Main Authors: Natsumeda, Manabu, Kanemaru, Yu, On, Jotaro, Saito, Shoji, Tsukamoto, Yoshihiro, Okada, Masayasu, Hiraishi, Tetsuya, Oishi, Makoto, Fujii, Yukihiko
格式: Artigo
語言:Inglês
出版: Oxford University Press 2020
主題:
Supplement Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7699082/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdaa143.034
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍